Compression Garments on Hypermobility Type of Ehlers-Danlos Syndrome (CGhEDS)

Hypermobility Type Ehlers-Danlos Syndrome Clinical Trial

— VECO  

Official title:

Compression Garments Effects on Postural Balance of Patients With Hypermobility Type of Ehlers-danlos Syndrome, a Prospective Study on 40 Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03359135
• Other study ID #: hEDS-40
• Status: Not yet recruiting
• Phase: N/A
• First received: November 27, 2017
• Last updated: February 27, 2018
• Start date: April 1, 2018
• Est. completion date: April 2019

Study information

• Verified date: February 2018
• Source: Hôpital Raymond Poincaré
• Contact: BENISTAN Karelle, Dr
• Phone: 0033147104440
• Email: karelle.benistan[@]aphp.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study evaluates the effects of wearing a compression garment on the postural balance of patients with hypermobility type of Ehlers-Danlos syndrome, in randomised controlled study.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 40
• Est. completion date: April 2019
• Est. primary completion date: October 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Age =16 years

• hEDS with the 2017 diagnostic criteria .

• A normal neurological examination with no sensory disorders, no cerebellar syndrome or vestibular syndrome.

• An optimal balanced analgesic treatment before inclusion

• Patients who have not modified their physical treatment (physiotherapy) since 6 months.

Exclusion Criteria:

• Surgery of the lower limb (hip, knee or ankle)

• Patient having already wear compression garments in the year preceding.

• Neurological history of sensory , vestibular or cerebellar disorders.

Related Conditions & MeSH terms

• Ehlers-Danlos Syndrome
• Hypermobility Type Ehlers-Danlos Syndrome
• Syndrome

Intervention

Other:
• Rehabilitation
Rehabilitation during 4 weeks

Device:
• Compression Garment
Rehabilitation associated to wearing CG during 4 weeks

Locations

Country	Name	City	State
France	Gader Nadra	Garches

Sponsors (1)

Lead Sponsor	Collaborator
Hôpital Raymond Poincaré

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Centre of pression speed	a stability parameter on a force plate	4 weeks